Rankings
▼
Calendar
MIRM FY 2023 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$186M
+141.8% YoY
Gross Profit
$139M
74.8% margin
Operating Income
-$109M
-58.6% margin
Net Income
-$163M
-87.7% margin
EPS (Diluted)
$-4.00
Cash Flow
Operating Cash Flow
-$71M
Free Cash Flow
-$91M
Stock-Based Comp.
$35M
Balance Sheet
Total Assets
$647M
Total Liabilities
$398M
Stockholders' Equity
$249M
Cash & Equivalents
$286M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$186M
$77M
+141.8%
Gross Profit
$139M
$65M
+115.4%
Operating Income
-$109M
-$131M
+16.8%
Net Income
-$163M
-$136M
-20.5%
← Q4 2022
All Quarters
Q1 2023 →